The Central Maine Healthcare Quality Team’s focus is on quality and safety of healthcare provided at Central Maine Medical Center and other locations throughout the CMH health system. Pictured from left to right: Lorraine Theriault, Chelsea Ervin, Angela Dubuc, Kate Carpenter, Michelle Hosford, and Doris Laslie. (Not pictured: Jennifer Wells, Nancy Murphy, Janice Somerville, Kelly LeBlond, Dr. John Alexander)

LEWISTON — Central Maine Medical Center received its seventh consecutive “A” – the highest grade possible – for hospital safety from The Leapfrog Group. This national distinction recognizes CMMC’s success with protecting patients from harm and errors in the hospital.

“The recognition is well deserved and hard-earned as we work through these challenging times in healthcare,” said Steven G. Littleson, DBA, FACHE, president and CEO of Central Maine Healthcare. “I am incredibly thankful for all of our team members who are continuously committed to taking excellent care of our patients, as well as each other.”

The Leapfrog Group, an independent national watchdog organization, assigns an “A,” “B,” “C,” “D,” or “F” grade to general hospitals across the country based on over 30 national performance measures reflecting errors, injuries, accidents, and infections, as well as systems hospitals have in place to prevent harm.

“Our seventh consecutive ‘A’ from Leapfrog is a testament to the skills and dedication of our entire team of clinicians,” said Central Maine Healthcare Chief Medical Officer John L. Alexander, MD, MHCM, FACEP. “We are proud that our commitment to providing exceptional, safe healthcare services for all of our patients has been consistently recognized.”

Developed under the guidance of a national expert panel, the Leapfrog Hospital Safety Grade uses up to 27 measures of publicly available hospital safety data to assign grades to more than 2,700 U.S. acute-care hospitals twice a year. The Hospital Safety Grade’s methodology is peer-reviewed and fully transparent. The results are free to the public.

Comments are not available on this story.

filed under: